As part of MUSC's growing translational genomics program, a genomics tumor board has been created to bring diverse specialists together to help physicians diagnose and manage cancer. The team that advises the clinicians comprises basic scientists, pathologists, bioinformaticists, and geneticists.

More at Progressnotes, MUSC’s Medical Magazine